Biochemical aspects of X-linked adrenoleukodystrophy

Brain Pathology

Volumn 20, Issue 4, 2010, Pages 831-837

  Kemp, Stephan ^a   Wanders, Ronald ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

ALDP; ELOVL; Peroxisome; VLCFA

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER ALDP; BIOLOGICAL MARKER; ELONGATION OF VERY LONG CHAIN FATTY ACID LIKE 1; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; LONG CHAIN FATTY ACID; PROTEIN ABCD1; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID; ABCD1 PROTEIN, HUMAN; FATTY ACID;

ADRENOLEUKODYSTROPHY; CHEMICAL ANALYSIS; CHILDHOOD ADRENOLEUKODYSTROPHY; CONFERENCE PAPER; DIAGNOSTIC TEST; FATTY ACID OXIDATION; GENE MUTATION; GENETIC LINKAGE; HOMEOSTASIS; HUMAN; LIPID ANALYSIS; LIPID METABOLISM; LIPID PEROXIDATION; NEWBORN SCREENING; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PEROXISOME; PROTEIN FUNCTION; RISK FACTOR; X CHROMOSOME LINKED DISORDER; GENETICS; METABOLISM; MUTATION;

ADRENOLEUKODYSTROPHY; ATP-BINDING CASSETTE TRANSPORTERS; FATTY ACIDS; HUMANS; MUTATION;

EID: 77953228906     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2010.00391.x     Document Type: Conference Paper

References (85)

1. Agbaga MP, Brush RS, Mandal MN, Henry K, Elliott MH, Anderson RE (2008) Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids. Proc Natl Acad Sci U S A 105 : 12843 12848.
2. Asheuer M, Bieche I, Laurendeau I, Moser A, Hainque B, Vidaud M, Aubourg P (2005) Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy. Hum Mol Genet 14 : 1293 1303.
3. Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, Rocchiccioli F, Cartier N, Jambaque I et al (1993) A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy. N Engl J Med 329 : 745 752.
4. Berger J, Molzer B, Fae I, Bernheimer H (1994) X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes. Biochem Biophys Res Comm 205 : 1638 1643.
5. Bernert JT, Jr., Sprecher H (1979) Solubilization and partial purification of an enzyme involved in rat liver microsomal fatty acid chain elongation: beta-hydroxyacyl-CoA dehydrase. J Biol Chem 254 : 11584 11590.
6. Bezman L, Moser AB, Raymond GV, Rinaldo P, Watkins PA, Smith KD et al (2001) Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol 49 : 512 517.
7. Boehm CD, Cutting GR, Lachtermacher MB, Moser HW, Chong SS (1999) Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy. Mol Genet Metab 66 : 128 136.
8. Braiterman LT, Zheng S, Watkins PA, Geraghty MT, Johnson G, McGuinness MC et al (1998) Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins. Hum Mol Genet 7 : 239 247.
9. Brown FR, Van Duyn MA, Moser AB, Schulman JD, Rizzo WB, Snyder RD et al (1982) Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids. Johns Hopkins Med J 151 : 164 172.
10. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I et al (2009) Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326 : 818 823.
11. Cartier N, Lopez J, Moullier P, Rocchiccioli F, Rolland MO, Jorge P et al (1995) Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts. Proc Natl Acad Sci U S A 92 : 1674 1678.
12. Cinti DL, Cook L, Nagi MN, Suneja SK (1992) The fatty acid chain elongation system of mammalian endoplasmic reticulum. Prog Lipid Res 31 : 1 51.
13. Colli W, Hinkle PC, Pullman ME (1969) Characterization of the fatty acid elongation system in soluble extracts and membrane preparations of rat liver mitochondria. J Biol Chem 244 : 6432 6443.
14. Contreras M, Mosser J, Mandel JL, Aubourg P, Singh I (1994) The protein coded by the X-adrenoleukodystrophy gene is a peroxisomal integral membrane protein. FEBS Lett 344 : 211 215.
15. Cook L, Nagi MN, Suneja SK, Hand AR, Cinti DL (1992) Evidence that beta-hydroxyacyl-CoA dehydrase purified from rat liver microsomes is of peroxisomal origin. Biochem J 287 : 91 100.
16. Dean M, Rzhetsky A, Allikmets R (2001) The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11 : 1156 1166. (Pubitemid 32677289)
17. Denic V, Weissman JS (2007) A molecular caliper mechanism for determining very long-chain fatty acid length. Cell 130 : 663 677.
18. Eichler EE, Budarf ML, Rocchi M, Deaven LL, Doggett NA, Baldini A et al (1997) Interchromosomal duplications of the adrenoleukodystrophy locus: a phenomenon of pericentromeric plasticity. Hum Mol Genet 6 : 991 1002.
19. Engelen M, Ofman R, Dijkgraaf MGW, Hijzen M, van der Wardt LA, van Geel BM et al (2010) Lovastatin in X-linked adrenoleukodystrophy. N Engl J Med 362 : 276 277.
20. Fouquet F, Zhou JM, Ralston E, Murray K, Troalen F, Magal E et al (1997) Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system. Neurobiol Dis 3 : 271 285.
21. Fourcade S, Lopez-Erauskin J, Galino J, Duval C, Naudi A, Jove M et al (2008) Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum Mol Genet 17 : 1762 1773.
22. Fourcade S, Ruiz M, Camps C, Schluter A, Houten SM, Mooyer PAW et al (2009) A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. Am J Physiol Endocrinol Metab 296 : E211 E221.
23. Garashi M, Belchis D, Suzuki K (1976) Brain gangliosides in adrenoleukodystrophy. J Neurochem 27 : 327 328.
24. Halbach A, Lorenzen S, Landgraf C, Volkmer-Engert R, Erdmann R, Rottensteiner H (2005) Function of the PEX19-binding site of human adrenoleukodystrophy protein as targeting motif in man and yeast. PMP targeting is evolutionarily conserved. J Biol Chem 280 : 21176 21182.
25. Hashmi M, Stanley W, Singh I (1986) Lignoceroyl-CoASH ligase: enzyme defect in fatty acid beta-oxidation system in X-linked childhood adrenoleukodystrophy. FEBS Lett 196 : 247 250.
26. Hettema EH, van Roermund CW, Distel B, van Den Berg M, Vilela C, Rodrigues-Pousada C et al (1996) The ABC transporter proteins Pat1 and Pat2 are required for import of long-chain fatty acids into peroxisomes of Saccharomyces cerevisiae. EMBO J 15 : 3813 3822.
27. Ho JK, Moser H, Kishimoto Y, Hamilton JA (1995) Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy. J Clin Invest 96 : 1455 1463.
28. Hubbard WC, Moser AB, Liu AC, Jones RO, Steinberg SJ, Lorey F et al (2009) Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method. Mol Genet Metab 97 : 212 220.
29. Igarashi M, Schaumburg HH, Powers J, Kishmoto Y, Kolodny E, Suzuki K (1976) Fatty acid abnormality in adrenoleukodystrophy. J Neurochem 26 : 851 860.
30. Jakobsson A, Westerberg R, Jacobsson A (2006) Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res 45 : 237 249.
31. Jia Z, Moulson CL, Pei Z, Miner JH, Watkins PA (2007) Fatty acid transport protein 4 is the principal very long chain fatty acyl-CoA synthetase in skin fibroblasts. J Biol Chem 282 : 20573 20583. (Pubitemid 47100017)
32. Kannagi R, Nudelman E, Hakomori S (1982) Possible role of ceramide in defining structure and function of membrane glycolipids. Proc Natl Acad Sci U S A 79 : 3470 3474.
33. Kashiwayama Y, Seki M, Yasui A, Murasaki Y, Morita M, Yamashita Y et al (2009) 70-kDa peroxisomal membrane protein related protein (P70R/ABCD4) localizes to endoplasmic reticulum not peroxisomes, and NH2-terminal hydrophobic property determines the subcellular localization of ABC subfamily D proteins. Exp Cell Res 315 : 190 205.
34. Kemp S, Ligtenberg MJL, vanGeel BM, Barth PG, Wolterman RA, Schoute F et al (1994) Identification of A 2 base-pair deletion in 5 unrelated families with adrenoleukodystrophy - a possible hot-spot for mutations. Biochem Biophys Res Commun 202 : 647 653.
35. Kemp S, Wanders RJ (2007) X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Mol Genet Metab 90 : 268 276.
36. Kemp S, Wei HM, Lu JF, Braiterman LT, McGuinness MC, Moser AB et al (1998) Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy. Nat Med 4 : 1261 1268.
37. Kemp S, Valianpour F, Denis S, Ofman R, Sanders RJ, Mooyer P et al (2005) Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy. Mol Genet Metab 84 : 144 151.
38. Kishimoto Y, Moser HW, Kawamura N, Platt M, Pallante SL, Fenselau C (1980) Adrenoleukodystrophy: evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous origin. Biochem Biophys Res Commun 96 : 69 76.
39. Knazek RA, Rizzo WB, Schulman JD, Dave JR (1983) Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy. J Clin Invest 72 : 245 248.
40. Kobayashi T, Zadravec D, Jacobsson A (2007) ELOVL2 overexpression enhances triacylglycerol synthesis in 3T3-L1 and F442A cells. FEBS Lett 581 : 3157 3163.
41. Leonard AE, Pereira SL, Sprecher H, Huang YS (2004) Elongation of long-chain fatty acids. Prog Lipid Res 43 : 36 54.
42. Lu JF, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, Smith KD (1997) A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci U S A 94 : 9366 9371.
43. Matsuzaka T, Shimano H, Yahagi N, Yoshikawa T, Memiya-Kudo M, Hasty AH et al (2002) Cloning and characterization of a mammalian fatty acyl-CoA elongase as a lipogenic enzyme regulated by SREBPs. J Lipid Res 43 : 911 920.
44. McGuinness MC, Zhang HP, Smith KD (2001) Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. Mol Genet Metab 74 : 256 263.
45. Migeon BR, Moser HW, Moser AB, Axelman J, Sillence D, Norum RA (1981) Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells. Proc Natl Acad Sci U S A 78 : 5066 5070.
46. Moon YA, Hammer RE, Horton JD (2009) Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice. J Lipid Res 50 : 412 423.
47. Moon YA, Horton JD (2003) Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade. J Biol Chem 278 : 7335 7343.
48. Moon YA, Shah NA, Mohapatra S, Warrington JA, Horton JD (2001) Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins. J Biol Chem 276 : 45358 45366.
49. Moser AB, Kreiter N, Bezman L, Lu S, Raymond GV, Naidu S, Moser HW (1999) Plasma very long chain fatty acids in 3000 peroxisome disease patients and 29 000 controls. Ann Neurol 45 : 100 110.
50. Moser HW, Moser AB, Frayer KK, Chen W, Schulman JD, O'Neill BP, Kishimoto Y (1981) Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. Neurology 31 : 1241 1249.
51. Moser HW, Smith KD, Watkins PA, Powers J, Moser AB (2001) X-linked adrenoleukodystrophy. In : The Metabolic and Molecular Bases of Inherited Disease, CR Scriver, AL Beaudet, WS Sly, D Valle (eds), pp. 3257 3301. McGraw Hill
52. Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H et al (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361 : 726 730.
53. Nugteren DH (1965) The enzymic chain elongation of fatty acids by rat-liver microsomes. Biochim Biophys Acta 106 : 280 290.
54. Ofman R, Dijkstra IM, van Roermund CW, Burger N, Turkenburg M, van CA et al (2010) The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. EMBO Mol Med 2 : 90 97.
55. Oh CS, Toke DA, Mandala S, Martin CE (1997) ELO2 and ELO3, homologues of the Saccharomyces cerevisiae ELO1 gene, function in fatty acid elongation and are required for sphingolipid formation. J Biol Chem 272 : 17376 17384.
56. Osei P, Suneja SK, Laguna JC, Nagi MN, Cook L, Prasad MR, Cinti DL (1989) Topography of rat hepatic microsomal enzymatic components of the fatty acid chain elongation system. J Biol Chem 264 : 6844 6849. (Pubitemid 19114794)
57. Pestronk A (1991) Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve 14 : 927 936.
58. Peters C, Charnas LR, Tan Y, Ziegler RS, Shapiro EG, DeFor T et al (2004) Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 104 : 881 888.
59. Powers JM, DeCiero DP, Ito M, Moser AB, Moser HW (2000) Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J Neuropathol Exp Neurol 59 : 89 102.
60. Powers JM, Pei Z, Heinzer AK, Deering R, Moser AB, Moser HW et al (2005) Adreno-leukodystrophy: oxidative stress of mice and men. J Neuropathol Exp Neurol 64 : 1067 1079.
61. Powers JM, Schaumburg HH (1974) Adreno-leukodystrophy (sex-linked Schilder's disease). A pathogenetic hypothesis based on ultrastructural lesions in adrenal cortex, peripheral nerve and testis. Am J Pathol 76 : 481 491.
62. Pujol A, Hindelang C, Callizot N, Bartsch U, Schachner M, Mandel JL (2002) Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum Mol Genet 11 : 499 505.
63. Rizzo WB, Avigan J, Chemke J, Schulman JD (1984) Adrenoleukodystrophy: very long-chain fatty acid metabolism in fibroblasts. Neurology 34 : 163 169.
64. Roerig P, Mayerhofer P, Holzinger A, Gartner J (2001) Characterization and functional analysis of the nucleotide binding fold in human peroxisomal ATP binding cassette transporters. FEBS Lett 492 : 66 72.
65. Shinnoh N, Yamada T, Yoshimura T, Furuya H, Yoshida Y, Suzuki Y et al (1995) Adrenoleukodystrophy: the restoration of peroxisomal beta-oxidation by transfection of normal cDNA. Biochem Biophys Res Commun 210 : 830 836.
66. Singh H, Brogan M, Johnson D, Poulos A (1992) Peroxisomal beta-oxidation of branched chain fatty acids in human skin fibroblasts. J Lipid Res 33 : 1597 1605.
67. Singh I, Khan M, Key L, Pai S (1998) Lovastatin for X-linked adrenoleukodystrophy. N Engl J Med 339 : 702 703.
68. Singh I, Moser AE, Moser HW, Kishimoto Y (1984) Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes. Pediatr Res 18 : 286 290.
69. Smith KD, Kemp S, Braiterman LT, Lu JF, Wei HM, Geraghty M et al (1999) X-linked adrenoleukodystrophy: genes, mutations, and phenotypes. Neurochem Res 24 : 521 535.
70. Smith S (1994) The animal fatty acid synthase: one gene, one polypeptide, seven enzymes. FASEB J 8 : 1248 1259.
71. Tanaka AR, Tanabe K, Morita M, Kurisu M, Kasiwayama Y, Matsuo M et al (2002) ATP binding/hydrolysis by and phosphorylation of peroxisomal ATP-binding cassette proteins PMP70 (ABCD3) and adrenoleukodystrophy protein (ABCD1). J Biol Chem 277 : 40142 40147.
72. Theda C, Moser AB, Powers JM, Moser HW (1992) Phospholipids in X-linked adrenoleukodystrophy white matter: fatty acid abnormalities before the onset of demyelination. J Neurol Sci 110 : 195 204.
73. Toke DA, Martin CE (1996) Isolation and characterization of a gene affecting fatty acid elongation in Saccharomyces cerevisiae. J Biol Chem 271 : 18413 18422.
74. Tsuji S, Sano T, Ariga T, Miyatake T (1981) Increased synthesis of hexacosanoic acid (C26:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). J Biochem (Tokyo) 90 : 1233 1236.
75. Tvrdik P, Westerberg R, Silve S, Asadi A, Jakobsson A, Cannon B et al (2000) Role of a new mammalian gene family in the biosynthesis of very long chain fatty acids and sphingolipids. J Cell Biol 149 : 707 718.
76. Valianpour F, Selhorst JJ, van Lint LE, van Gennip AH, Wanders RJ, Kemp S (2003) Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry. Mol Genet Metab 79 : 189 196.
77. van Geel BM, Assies J, Haverkort EB, Koelman JH, Verbeeten B, Wanders RJ, Barth PG (1999) Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil." J Neurol Neurosurg Psychiatry 67 : 290 299.
78. van Roermund CWT, Visser WF, IJlst L, van Cruchten A, Boek M, Kulik W et al (2008) The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. FASEB J 22 : 4201 4208.
79. Vasireddy V, Uchida Y, Salem N Jr., Kim SY, Mandal MN, Reddy GB et al (2007) Loss of functional ELOVL4 depletes very long-chain fatty acids (>or = C28) and the unique omega-O-acylceramides in skin leading to neonatal death. Hum Mol Genet 16 : 471 482.
80. Wakil SJ (1989) Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 28 : 4523 4530.
81. Wanders RJ, Ferdinandusse S, Brites P, Kemp S (2010) Peroxisomes, lipid metabolism and lipotoxicity. Biochim Biophys Acta 1801 : 272 280.
82. Wanders RJ, van Roermund CW, van Wijland MJ, Schutgens RB, van den BH, Schram AW, Tager JM (1988) Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids. Biochem Biophys Res Commun 153 : 618 624.
83. Westerberg R, Tvrdik P, Unden AB, Mansson JE, Norlen L, Jakobsson A et al (2004) Role for ELOVL3 and fatty acid chain length in development of hair and skin function. J Biol Chem 279 : 5621 5629.
84. Whitcomb RW, Linehan WM, Knazek RA (1988) Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro. J Clin Invest 81 : 185 188.
85. Zhang K, Kniazeva M, Han M, Li W, Yu Z, Yang Z et al (2001) A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet 27 : 89 93.